CMH :: Clinical and Molecular Hepatology

Influence of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with HBV-related acute-on-chronic liver failure

Rui-Min Lai, Li-Xi Yao, Shan Lin, Jia-Hui Zhou, Bing-Ping Liu, Zhao-Yi Liang, Tianbin Chen, Jia-Ji Jiang, Qi Zheng, Yueyong Zhu

Expert Review of Gastroenterology & Hepatology.2024; 18(1-3): 103. CrossRef

Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients

World Journal of Hepatology.2024; 16(1): 109. CrossRef

Effect of metabolic dysfunction‑associated fatty liver disease on the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A systematic review and meta‑analysis

Experimental and Therapeutic Medicine.2024;[Epub] CrossRef

Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B

Danny Con, Steven Tu, Daniel Clayton-Chubb, John S. Lubel, Amanda J. Nicoll, Rohit Sawhney, Stephen Bloom

Digestive Diseases and Sciences.2024;[Epub] CrossRef

Hepatic steatosis: Ultrasound assessment using attenuation imaging (ATI) with liver biopsy correlation

Christopher J Welman, Jacqualine Saunders, Marilyn Zelesco, Steven Abbott, Glenn Boardman, Oyekoya T Ayonrinde

Journal of Medical Imaging and Radiation Oncology.2023; 67(1): 45. CrossRef

Concomitant Diseases and Co-contribution on Progression of Liver Stiffness in Patients with Hepatitis B Virus Infection

Chang-Hai Liu, Wei Jiang, Dong-Bo Wu, Qing-Min Zeng, You-Juan Wang, Hong Tang

Digestive Diseases and Sciences.2023; 68(4): 1605. CrossRef

The interplay of long noncoding RNAs and hepatitis B virus

Nima Sarfaraz, Srinivas Somarowthu, Michael J. Bouchard

Steatosis, HBV‐related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta‐analysis

Xianhua Mao, Ka Shing Cheung, Chengzhi Peng, Lung‐Yi Mak, Ho Ming Cheng, James Fung, Noam Peleg, Howard H.‐W. Leung, Rajneesh Kumar, Jeong‐Hoon Lee, Amir Shlomai, Man‐Fung Yuen, Wai‐Kay Seto

Letter: metabolic dysfunction‐associated fatty liver disease increases risk of all‐cause mortality in patients with chronic hepatitis C

Alimentary Pharmacology & Therapeutics.2023; 57(2): 272. CrossRef

The association of fatty liver and risk of hepatocellular carcinoma in HBV or HCV infected individuals: a systematic review and meta-analysis

Cheng-Long Han, Bao-Wen Tian, Chun-Cheng Yang, Ya-Fei Yang, Yun-Long Ma, Zi-Niu Ding, Lun-Jie Yan, Hui Liu, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Dong-Xu Wang, Tao Li

Expert Review of Gastroenterology & Hepatology.2023; 17(2): 189. CrossRef

Hepatitis B virus infection combined with nonalcoholic fatty liver disease: Interaction and prognosis

Lili Liu, Hong Li, Yang Zhang, Jing Zhang, Zhenhuan Cao

Liver fibrosis is closely related to metabolic factors in metabolic associated fatty liver disease with hepatitis B virus infection

Haifeng Lv, Yanming Jiang, Geli Zhu, Shiyi Liu, Dian Wang, Jie Wang, Ke Zhao, Jing Liu

Positive hepatitis B core antibody is associated with advanced fibrosis and mortality in nonalcoholic fatty liver disease

Pengyan Zhang, Zhenqiu Liu, Hong Fan, Tingting Shi, Xinyu Han, Chen Suo, Xingdong Chen, Tiejun Zhang

European Journal of Gastroenterology & Hepatology.2023; 35(3): 294. CrossRef

A novel non‐invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD

Jian Wang, Rui Huang, Jiacheng Liu, Ruimin Lai, Yilin Liu, Chuanwu Zhu, Yuanwang Qiu, Zebao He, Shengxia Yin, Yuxin Chen, Xiaomin Yan, Weimao Ding, Qi Zheng, Jie Li, Chao Wu

Journal of Viral Hepatitis.2023; 30(4): 287. CrossRef

Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease

World Journal of Hepatology.2023; 15(2): 237. CrossRef

Impact of MAFLD on the complications after hepatectomy in patients with HBV-related hepatocellular carcinoma

Ke-Gong Xiong, Tai-Shun Lin, Jin-Feng Kong, Qing-Biao Lin, Li-Fang Chen, Kun-Yu Ke

Pyroptosis, Metabolism, and Oxidation in Tumorigenesis: Mechanisms and Therapeutic Implications

Qi Cao, Jia-Bao Zhang, Di-Yang Sun, Jiang-Tao Fu, Wen-Bin Wu, Xiao-Fei Chen, Dong-Jie Li, Pei Wang

Antioxidants & Redox Signaling.2023; 39(7-9): 512. CrossRef

The hepatitis B virus promotes the progression of non-alcoholic fatty liver disease through incomplete autophagy

Yang Wang, Jiaxi Li, Shanshan Wang, Yuheng Pang, Pengxiang Liu, Bangxiang Xie, Shuangshuang Dou, Tongwang Yang, Xiaoni Liu, Ying Shi, Dexi Chen

Free Radical Biology and Medicine.2023; 204: 326. CrossRef

Impact of prior HBV, HAV, and HEV infection on non‐alcoholic fatty liver disease

Stephanos Vassilopoulos, Markos Kalligeros, Athanasios Vassilopoulos, Fadi Shehadeh, Gregorio Benitez, Matthew Kaczynski, Ingrid Lazaridou, Kittichai Promrat, Jack R. Wands, Eleftherios Mylonakis

Journal of Viral Hepatitis.2023; 30(8): 685. CrossRef

Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma

Byeong Geun Song, Sung Chul Choi, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Seung Woon Paik

Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis

Yu Jun Wong, Vy H. Nguyen, Hwai-I Yang, Jie Li, Michael Huan Le, Wan-Jung Wu, Nicole Xinrong Han, Khi Yung Fong, Elizebeth Chen, Connie Wong, Fajuan Rui, Xiaoming Xu, Qi Xue, Xin Yu Hu, Wei Qiang Leow, George Boon-Bee Goh, Ramsey Cheung, Grace Wong, Vince

Clinical and Molecular Hepatology.2023; 29(3): 705. CrossRef

The Global Prevalence of Nonalcoholic Fatty Liver Disease and its Association With Cancers: Systematic Review and Meta-Analysis

Nor Asiah Muhamad, Nur Hasnah Maamor, Fatin Norhasny Leman, Zuraifah Asrah Mohamad, Sophia Karen Bakon, Mohd Hatta Abdul Mutalip, Izzah Athirah Rosli, Tahir Aris, Nai Ming Lai, Muhammad Radzi Abu Hassan

Interactive Journal of Medical Research.2023; 12: e40653. CrossRef

Tenofovir alafenamide significantly increased serum lipid levels compared with entecavir therapy in chronic hepatitis B virus patients

Rui-Min Lai, Shan Lin, Miao-Miao Wang, Na Li, Jia-Hui Zhou, Xiao-Yu Lin, Tian-Bin Chen, Yue-Yong Zhu, Qi Zheng

World Journal of Hepatology.2023; 15(8): 964. CrossRef

Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV–HIV Co-infected Adults

Richard K. Sterling, Wendy C. King, Mandana Khalili, David E. Kleiner, Amanda S. Hinerman, Mark Sulkowski, Raymond T. Chung, Mamta K. Jain, M auricio Lisker-Melman, David K. Wong, Marc G. Ghany

Digestive Diseases and Sciences.2022; 67(2): 676. CrossRef

Should We Treat Immune Tolerant Chronic Hepatitis B? Lessons from Asia

Journal of Clinical and Experimental Hepatology.2022; 12(1): 144. CrossRef

Comparison of biochemical response during antiviral treatment in patients with chronic hepatitis B infection

Si Ho Kim, Eun Ju Cho, Boo‐ok Jang, Kyunghan Lee, Jae Kyun Choi, Gwang Hyeon Choi, Jeong‐Hoon Lee, Su Jong Yu, Yoon Jun Kim, Yun Bin Lee, Jeong‐Hwan Yoon, Jin‐Wook Kim, Sook‐Hyang Jeong, Eun Sun Jang

Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver

Mi Na Kim, Kyungdo Han, Juhwan Yoo, Seong Gyu Hwang, Sang Hoon Ahn

Alimentary Pharmacology & Therapeutics.2022; 55(1): 97. CrossRef

Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC

Lei Liu, Si Xie, Yu-Xian Teng, Zhu-Jian Deng, Kang Chen, Hao-Tian Liu, Rong-Rui Huo, Xiu-Mei Liang, Ping-Ping Guo, Da-Long Yang, Liang Ma, Bang-De Xiang, Le-Qun Li, Jian-Hong Zhong

Severe Hepatic Steatosis Is Associated With Low-Level Viremia and Advanced Fibrosis in Patients With Chronic Hepatitis B in North America

Hin Hin Ko, Nishi H. Patel, Sarah Haylock-Jacobs, Karen Doucette, Mang M. Ma, Curtis Cooper, Erin Kelly, Magdy Elkhashab, Edward Tam, Robert Bailey, Alexander Wong, Gerald Minuk, Philip Wong, Scott K. Fung, Giada Sebastiani, Alnoor Ramji, Carla S. Coffin

MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients

Xiaoman Chen, Jing Zhou, Lili Wu, Xiang Zhu, Hong Deng

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 673. CrossRef

Validation for models for tumor recurrence after liver transplantation in hepatectomy patients

Sung Joon Kim, Jong Man Kim, Nam-Joon Yi, Gyu-Seong Choi, Kwang-Woong Lee, Kyung-Suk Suh, Jae-Won Joh

Annals of Surgical Treatment and Research.2022; 102(3): 131. CrossRef

A Novel Noninvasive Diagnostic Model of HBV-Related Inflammation in Chronic Hepatitis B Virus Infection Patients With Concurrent Nonalcoholic Fatty Liver Disease

Xuemei Tao, Lin Chen, Youfei Zhao, Yonggang Liu, Ruifang Shi, Bei Jiang, Yuqiang Mi, Liang Xu

Hepatitis B Core-Related Antigen Is Useful for Predicting Phase and Prognosis of Hepatitis B e Antigen-Positive Patients

Han Ah Lee, Hyun Woong Lee, Younhee Park, Hyon-Suk Kim, Yeon Seok Seo

Journal of Clinical Medicine.2022; 11(6): 1729. CrossRef

MAFLD enhances clinical practice for liver disease in the Asia-Pacific region

Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Mohammed Eslam, Jacob George, Takuji Torimura

Clinical and Molecular Hepatology.2022; 28(2): 150. CrossRef

Precision medicine in the era of potent antiviral therapy for chronic hepatitis B

Journal of Gastroenterology and Hepatology.2022; 37(7): 1191. CrossRef

Metabolic Risk Factors Are Associated with the Disease Severity and Prognosis of Hepatitis B Virus-Related Acute on Chronic Liver Failure

Lu Chen, Jinjin Dai, Qing Xie, Xiaolin Wang, Wei Cai

Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia

Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases

Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim

Clinical and Molecular Hepatology.2022; 28(3): 425. CrossRef

Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease

Han Ah Lee, Seung-seob Kim, Jin-Young Choi, Yeon Seok Seo, Beom Jin Park, Ki Choon Sim, Seung Up Kim

Clinical impact and mechanisms of hepatitis B virus infection concurrent with non-alcoholic fatty liver disease

Xin Tong, Yu Song, Shengxia Yin, Jian Wang, Rui Huang, Chao Wu, Junping Shi, Jie Li

Chinese Medical Journal.2022; 135(14): 1653. CrossRef

Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name

Clinical and Molecular Hepatology.2022; 28(4): 790. CrossRef

Progress in understanding of association between metabolic associated fatty liver disease and viral infectious diseases

World Chinese Journal of Digestology.2022; 30(18): 783. CrossRef

Interaction and Possible Mechanism between Non-Alcoholic Fatty Liver Disease and Chronic Hepatitis B

Advances in Clinical Medicine.2022; 12(11): 10453. CrossRef

Radiomics Analysis of Magnetic Resonance Proton Density Fat Fraction for the Diagnosis of Hepatic Steatosis in Patients With Suspected Non-Alcoholic Fatty Liver Disease

Ki Choon Sim, Min Ju Kim, Yongwon Cho, Hyun Jin Kim, Beom Jin Park, Deuk Jae Sung, Na Yeon Han, Yeo Eun Han, Tae Hyung Kim, Yoo Jin Lee

Journal of Korean Medical Science.2022;[Epub] CrossRef

Clinical study of ganshuang granule combined with tenofovir in the treatment of chronic hepatitis B complicated with nonalcoholic fatty liver disease

NAFLD and HBV interplay - related mechanisms underlying liver disease progression

Evanthia Tourkochristou, Stelios F. Assimakopoulos, Konstantinos Thomopoulos, Markos Marangos, Christos Triantos

Secondary prevention of hepatitis B virus‐related hepatocellular carcinoma with current antiviral therapies

The Kaohsiung Journal of Medical Sciences.2021; 37(4): 262. CrossRef

HRD1 attenuates the high uptake of [18F]FDG in hepatocellular carcinoma PET imaging

Ai-Mei Li, Xia-Wen Lin, Jing-Tao Shen, Min Li, Qi-Huang Zheng, Zheng-Yang Zhou, Ming Shi

Nuclear Medicine and Biology.2021; 96-97: 27. CrossRef

The FIB-4 Index Is a Useful Predictor for the Development of Hepatocellular Carcinoma in Patients with Coexisting Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B

Minah Kim, Yeonju Lee, Jun Sik Yoon, Minjong Lee, So Shin Kye, Sun Woong Kim, Yuri Cho

Association of Metabolic Risk Factors With Risks of Cancer and All‐Cause Mortality in Patients With Chronic Hepatitis B

Yun Bin Lee, Hyemi Moon, Jeong‐Hoon Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Fabien Zoulim, Juneyoung Lee, Jung‐Hwan Yoon

Pian Yu, Xu Zhang, Nian Liu, Ling Tang, Cong Peng, Xiang Chen

Signal Transduction and Targeted Therapy.2021;[Epub] CrossRef

Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B

Laurens A. van Kleef, Hannah S.J. Choi, Willem P. Brouwer, Bettina E. Hansen, Keyur Patel, Robert A. de Man, Harry L.A. Janssen, Robert J. de Knegt, Milan J. Sonneveld

Systematic review with meta‐analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B

Qi Zheng, Biyao Zou, Yuankai Wu, Yeehui Yeo, Huizhen Wu, Christopher D Stave, Ramsey C. Cheung, Mindie H. Nguyen

Alimentary Pharmacology & Therapeutics.2021; 54(9): 1100. CrossRef

Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy

Rong Fan, Junqi Niu, Hong Ma, Qing Xie, Jun Cheng, Huiying Rao, Xiaoguang Dou, Jianping Xie, Wei Zhao, Jie Peng, Zhiliang Gao, Hongbo Gao, Xinyue Chen, Jinjun Chen, Qiang Li, Hong Tang, Zhengang Zhang, Hong Ren, Mingliang Cheng, Xieer Liang, Chaonan Zhu,

Alimentary Pharmacology & Therapeutics.2021; 54(3): 329. CrossRef

Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy

Joo Hyun Oh, Hye Won Lee, Dong Hyun Sinn, Jun Yong Park, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Wonseok Kang, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik

Hepatology International.2021; 15(4): 892. CrossRef

Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion

World Journal of Gastroenterology.2021; 27(26): 3971. CrossRef

The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B

Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim

Journal of Hepatocellular Carcinoma.2021; Volume 8: 467. CrossRef

Clinical Gastroenterology and Hepatology.2020; 18(1): 264. CrossRef

Magnetic resonance imaging of obesity and metabolic disorders: Summary from the 2019 ISMRM Workshop

Houchun H. Hu, Rosa Tamara Branca, Diego Hernando, Dimitrios C. Karampinos, Jürgen Machann, Charles A. McKenzie, Holden H. Wu, Takeshi Yokoo, S. Sendhil Velan

Magnetic Resonance in Medicine.2020; 83(5): 1565. CrossRef

Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis

Miao Fang, Min Yao, Jie Yang, Wen-Jie Zheng, Li Wang, Deng-Fu Yao

World Journal of Gastrointestinal Oncology.2020; 12(1): 66. CrossRef

Chronic hepatitis B and non‐alcoholic fatty liver disease: Conspirators or competitors?

Jianbin Zhang, Shuangzhe Lin, Daixi Jiang, Mengting Li, Yuanwen Chen, Jun Li, Jiangao Fan

Earlier Alanine Aminotransferase Normalization During Antiviral Treatment Is Independently Associated With Lower Risk of Hepatocellular Carcinoma in Chronic Hepatitis B

Jonggi Choi, Gi-Ae Kim, Seungbong Han, Young-Suk Lim

American Journal of Gastroenterology.2020; 115(3): 406. CrossRef

Approach to the patient with chronic hepatitis B and decompensated cirrhosis

Presence of Hepatic Steatosis Does Not Increase the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Over Long Follow-Up

Chong Teik Lim, George Boon Bee Goh, Huihua Li, Tony Kiat-Hon Lim, Wei Qiang Leow, Wei Keat Wan, Rafay Azhar, Wan Cheng Chow, Rajneesh Kumar

Microbiology Insights.2020; 13: 117863612091887. CrossRef

Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B

Radiologic Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Suppressed Chronic Hepatitis B

Hyeki Cho, Young Chang, Jeong-Hoon Lee, Young Youn Cho, Joon Yeul Nam, Yun Bin Lee, Dong Ho Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jeong Min Lee, Jung-Hwan Yoon

Journal of Clinical Gastroenterology.2020; 54(7): 633. CrossRef

A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B

Hira Hanif, Muzammil M. Khan, Mukarram J. Ali, Pir A. Shah, Jinendra Satiya, Daryl T.Y. Lau, Aysha Aslam

Letter: fatty liver disease could have been a confounding factor for phase change in patients with chronic hepatitis B in the immune‐tolerant phase—authors' reply

Alimentary Pharmacology & Therapeutics.2020; 52(6): 1094. CrossRef

The Effects of Hepatic Steatosis on the Natural History of HBV Infection

Idrees Suliman, Noha Abdelgelil, Farah Kassamali, Tarek I. Hassanein

Clinics in Liver Disease.2019; 23(3): 433. CrossRef